23 Jul 2014 07:00
GlaxoSmithKline (GSK) reports its second quarter interims on Wednesday amid an investigation over a bribery scandal in China. Panmure Gordon said it is "not expecting fireworks" from GSK's results. "In light of our recent downgrade to forecasts due to exchange rate headwinds, we are expecting anoth
Read more